Abstract
Objective: To observe the clinical effect of integrative Chinese and western medicine (IC-WM) in treatment of patients with severe acute respiratory syndrome (SARS) and its influence on their T-lymphocyte subsets.Methods: Fifty-one patients with SARS of severe type were observed with synchronous non-randomized controlled method. They were divided into the ICWM group (29 patients) and the western medicine (WM) group (22 patients). Western medical treatment was applied to both groups, but to the ICWM group, Chinese medicine was given additionally. The therapeutic course was 2–3 weeks for both groups. Clinical effect and changes of T-lymphocyte subsets (CD4+) after treatment were observed.Results: In the ICWM group, 26 patients (89. 66%) were cured and 3 (10. 34%) died, while in the WM group, 12 (54. 55%) cured and 10 (45. 45%) died, thus comparison of the cure rate between the two groups showing significant difference (P <0.01). The score of clinical symptoms in the ICWM group was decreased from 7.14±5.20 scores before treatment to 1.82±3.75 scores after treatment, while in the WM group, it lowered from 7. 36±3.84 scores before treatment to517±417 scores after treatment, significant difference shown in the comparison of the values between the two groups after treatment (P < 0.01). Immunological function test showed that CD4+ T-lymphocyte in the ICWM group rose from 361 ± 278 cells/mm3 before treatment to 630 ± 454 cells/mm3 after treatment, showing significant difference (P < 001); but in the WM group, it merely rose from 288±186 cells/mm3 to 376±285 cells/mm3 in the corresponding period (P > 0.05).Conclusion: ICWM could improve the clinical symptoms of SARS patients markedly, enhance their T-lymphocyte immune function, and reduce their mortality.
Article PDF
Similar content being viewed by others
References
ZHU YY, CAI BQ. Diagnosis and treatment of severe acute respiratory syndrome. Beijing: People’s Health Publishing Press, 2003: 209–210.
Research Group of Clinical Information, China Academy of TCM. Technical protocol for prevention and treatment of severe acute respiratory syndrome by TCM. Information on Clinical Research of Treatment of SARS by Integrative Chinese and Western Medicine (Part 2).
LI TS, QIU ZF, HAN Y, et al. Preliminary study on pathogenesis of SARS. China Medical Tribune—Progress of Study on SARS (1st Collection). 2003: 40 –42.
LI XH, ZHANG K, HU JH, et al. Clinical observation on therapeutic effect of integrative Chinese and western medicine in treating SARS. CJIM(Chin) 2003; 23(7): 489–491.
ZHAO CH, GUO YB, WU H, et al. Analysis of clinical characteristics, therapeutic effect and outcome of 108 SARS patients in Beijing. CMJ 2003; 83(11): 897–901.
Drosten C, Cunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;(10): 1967–1976.
Ksiazek TG, Erdman D, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;(10): 1953–1966.
Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome. N Engl J Med 2003; (10): 1995–2005.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the Item of Special Scientific and Technological Action in Preventing and Treating SARS funded by State Administration of TCM (No. 2003AA20810)
Rights and permissions
About this article
Cite this article
Xiu-hui, L., Jian-hua, H., Ke, Z. et al. Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets. Chin. J. Integr. Med. 9, 263–265 (2003). https://doi.org/10.1007/BF02838611
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02838611